ICD-10 Coding for Extrapyramidal Syndromes(G25.1, G25.1B, G25.1D)
Explore comprehensive ICD-10 coding for extrapyramidal syndromes, including drug-induced parkinsonism and unspecified movement disorders. Ensure accurate documentation and coding compliance.
Complete code families applicable to Extrapyramidal Syndromes
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| G25.1 | Drug-induced parkinsonism | Use when parkinsonian symptoms develop after drug exposure, particularly antipsychotics. |
|
| G25.9 | Extrapyramidal and movement disorder, unspecified | Use as a last resort when specific type of EPS cannot be determined. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutExtrapyramidal Syndromes
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Extrapyramidal Syndromes.
Failure to document drug relationship
Impact
Clinical: Misleading clinical picture affecting treatment decisions., Regulatory: Non-compliance with coding standards., Financial: Potential claim denials or reduced reimbursement.
Mitigation
Always document drug exposure and symptom onset., Use templates to ensure completeness.
Using G25.9 without specific symptom documentation
Impact
Reimbursement: Potential denial or reduced reimbursement due to lack of specificity., Compliance: Increased risk of non-compliance with coding guidelines., Data Quality: Poor data quality affecting clinical decision-making.
Mitigation
Ensure detailed documentation of symptoms and drug history.
Use of unspecified codes
Impact
High risk of audit due to lack of specificity in coding.
Mitigation
Ensure detailed documentation and use specific codes where possible.